Results of the JAVELIN Gastric 100 phase 3 trial: avelumab maintenance following first-line (1L) chemotherapy (CTx) vs continuation of CTx for HER2-advanced gastric or gastroesophageal junction cancer (GC/GEJC)

Moehler M. H. , Dvorkin M., Ozguroglu M. , Ryu M., Muntean A. S. , Lonardi S., ...More

Gastrointestinal Cancers Symposium of the American-Society-of-Clinical-Oncology, San-Francisco, Costa Rica, 23 - 25 January 2020, vol.38 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 38
  • City: San-Francisco
  • Country: Costa Rica